Immunology

SIV shrugs off antibodies in vaccinated monkeys

New research on monkeys vaccinated against HIV's relative SIV calls into question an idea that has driven AIDS vaccine work for years. The assumption: a protective vaccine only needs to stimulate moderate levels of antibodies ...

HIV & AIDS

Researchers identify potential new HIV vaccine/therapy target

After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, ...

HIV & AIDS

Novel tool visualizes whole body SIV replication

A collaborative effort between investigators at the Yerkes National Primate Research Center, Emory University School of Medicine and Georgia Institute of Technology has led to the development of a non-invasive method to image ...

HIV & AIDS

Developing a new vaccination strategy against AIDS

According to the WHO, there are currently more than 36 million people infected with the human immunodeficiency virus (HIV) and a further 2.4 million become infected every year. Despite treatment success against the virus, ...

page 2 from 4